Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD.

STUDY OBJECTIVE To evaluate the short-form 36-item questionnaire (SF-36) as an instrument for measuring health-related quality of life (HRQL) in patients with symptomatic COPD. DESIGN Observational data at a single point in time. SETTING Outpatient pulmonary clinic. PATIENTS Fifty male patients with COPD and no significant comorbidity. MEASUREMENTS AND RESULTS HRQL was assessed with the SF-36, which consists of 36 questions that cover nine health domains. Clinical ratings of dyspnea were measured by the multidimensional baseline dyspnea index (BDI). Pulmonary function tests included forced vital capacity (FVC), forced expiratory volume in 1 s (FEV1), and maximal inspiratory mouth pressure (PImax). The mean (+/- SD) age of the patients was 72 +/- 8 years. The BDI focal score was 5.6 +/- 2.3, FEV1 was 1.32 +/- 0.60 L (48 +/- 22% pred), and PImax was 62 +/- 23 cm H2O. The BDI focal score was significantly correlated with seven of nine components of the SF-36 (range of r, 0.42 to 0.91; p < 0.05). The FEV1 percent of predicted and PImax were significantly correlated with five of nine health components (range of r, 0.30 to 0.65 and 0.31 to 0.61, respectively). Using linear regression model analysis with the different SF-36 components as the dependent variable and BDI, FVC, FEV1, and PImax as independent variables, the BDI score was the only significant predictor of social and physical functioning, role-physical, vitality, pain, health perceptions, and health transition (p < 0.05). CONCLUSIONS The SF-36 is a valid instrument to measure HRQL in patients with COPD. The severity of dyspnea but not respiratory function was a significant predictor of various components of HRQL.

[1]  D. Postma,et al.  Quality of Life in Patients With Chronic Obstructive Pulmonary Disease Improves After Rehabilitation at Home , 1995 .

[2]  J. Ware,et al.  Quality of life in asthma. I. Internal consistency and validity of the SF-36 questionnaire. , 1994, American journal of respiratory and critical care medicine.

[3]  P. Jones,et al.  Quality of life, symptoms and pulmonary function in asthma: long-term treatment with nedocromil sodium examined in a controlled multicentre trial. Nedocromil Sodium Quality of Life Study Group. , 1994, The European respiratory journal.

[4]  C. van Weel,et al.  Two-year bronchodilator treatment in patients with mild airflow obstruction. Contradictory effects on lung function and quality of life. , 1992, Chest.

[5]  G. Colice,et al.  Impact of dyspnea and physiologic function on general health status in patients with chronic obstructive pulmonary disease. , 1992, Chest.

[6]  P. Jones,et al.  A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. , 1992, The American review of respiratory disease.

[7]  C. Sherbourne,et al.  The MOS 36-Item Short-Form Health Survey (SF-36) , 1992 .

[8]  Anastasia E. Raczek,et al.  The validity and relative precision of MOS short- and long-form health status scales and Dartmouth COOP charts. Results from the Medical Outcomes Study. , 1992, Medical care.

[9]  R. Deyo The quality of life, research, and care. , 1991, Annals of internal medicine.

[10]  P Littlejohns,et al.  Relationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in patients with chronic airflow limitation. , 1989, The American review of respiratory disease.

[11]  A. Stewart,et al.  Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. , 1989, JAMA.

[12]  A. Stewart,et al.  The MOS short-form general health survey. Reliability and validity in a patient population. , 1988, Medical care.

[13]  G. Guyatt,et al.  A measure of quality of life for clinical trials in chronic lung disease. , 1987, Thorax.

[14]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[15]  N. Anthonisen,et al.  Prognosis in chronic obstructive pulmonary disease. , 1990, The American review of respiratory disease.

[16]  G. Prigatano,et al.  Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. , 1984, Archives of internal medicine.

[17]  C. Wells,et al.  The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. , 1984, Chest.

[18]  R. Kaplan,et al.  Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease. , 1984, Journal of chronic diseases.

[19]  Life quality of patients with chronic obstructive pulmonary disease. , 1982, Archives of internal medicine.

[20]  J. Morris,et al.  Spirometric standards for healthy nonsmoking adults. , 2015, The American review of respiratory disease.

[21]  L. F. Black,et al.  Maximal respiratory pressures: normal values and relationship to age and sex. , 2015 .